Lv11
12 积分 2025-03-31 加入
Fc-Optimized Anti-CCR8 Antibody Depletes Regulatory T Cells in Human Tumor Models
43分钟前
待确认
CCR8: a promising therapeutic target against tumor-infiltrating regulatory T cells
2小时前
已完结
Enfortumab vedotin plus pembrolizumab versus chemotherapy in patients with previously untreated locally advanced or metastatic urothelial cancer (EV-302): patient-reported outcomes from an open-label, randomised, controlled, phase 3 study
20天前
已完结
Expression of the β6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling
20天前
已完结
Enfortumab vedotin-related pneumonitis is more common than expected and could lead to acute respiratory failure
22天前
已完结
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
23天前
已完结
CD300ld on neutrophils is required for tumour-driven immune suppression
26天前
已完结
CD300ld on pathologically activated neutrophils promotes tumor immune suppression by binding phosphatidylserine on CD8+ T cells
26天前
已完结
Signal co-operation between integrins and other receptor systems
1个月前
已完结
Vitiligo
1个月前
已完结
皖公网安备34019202002308
